Definitive Contract 75D30120C09509

Award Date 9/30/20
Potential Completion Date 3/28/22
Potential Value $348K
Federal Agency
CDC Pittsburgh
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Morgantown, WV 26505, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
3
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services (HHS) Centers for Disease Control and Prevention (CDC) awarded a $249,000.00 firm fixed-price purchase order to Emory University's Office of Sponsored Programs Division for biologicals. The work will be performed in Atlanta, Georgia and have a completion date of June 30, 2023. The contract is not set aside for a designated socioeconomic group. Emory University is a private research university that has a history of providing clinical trial, data...
The federal contract award 75D30121C10084 was issued by the Centers for Disease Control and Prevention (CDC) to Emory University for "SARS - COV-2 APPLIED RESEARCH FOR NCEZID". The $622,108.90 firm-fixed price contract runs through November 28, 2022 and does not have a set-aside designation. Emory University, a private research university based in Atlanta, Georgia, has an extensive track record of performing federally funded research and providing services to the government. This...
This is a $10,168,423.08 definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to Emory University, a private research institution in Atlanta, Georgia, for the provision of clinic care services. The contract has an ultimate completion date of August 31, 2020 and is a cost-no-fee arrangement. Emory University is a major recipient of federal contracts and grants, with an extensive track record of conducting biomedical research, public health, and clinical studies...
Emory University Office of Sponsored Programs Division was awarded a $96,146 firm fixed price contract by the Centers for Disease Control and Prevention for support of the SARS COV-2 Broad Agency Announcement. No set-aside designation was applied. Work will be performed in Atlanta, Georgia through March 2022. This contract is likely associated with Emory University's previously awarded multiple award indefinite delivery contract from the CDC worth up to $86 million to provide clinical...
Emory University has been awarded a firm fixed price definitive contract valued at approximately $1.78 million by the Centers for Disease Control and Prevention (CDC) to support Topic 7.1 of the agency's Fiscal Year 2021 Broad Agency Announcement (BAA). As the prime contractor, Emory University will perform the work at its location in Chamblee, Georgia. The period of performance is August 1, 2021 through July 31, 2023. While details of the work requirements are not provided in the award...
This is a $245,000 firm fixed-price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Emory University, a private research institution in Atlanta, Georgia. The contract, titled "EMORY-SARS COV2 CRYIEM," is for research and services related to the COVID-19 virus. The contract has an ultimate completion date of August 30, 2024. Emory University is a major recipient of federal contracts and grants, particularly in the areas of biomedical...
<p>The Centers for Disease Control and Prevention (CDC) awarded a $1,807,738 definitive contract to Emory University Office of Sponsored Programs Division, doing business as Emory University, to provide services and research under Broad Agency Announcement Topic 33.1. The place of performance will be in Atlanta, Georgia, and the firm fixed price contract period runs from September 11, 2023 through September 10, 2025. No subcontractors were identified.</p>
This contract, awarded by the Department of Health and Human Services Centers for Disease Control and Prevention (CDC) to Emory University, is for &quot;BLOOD DRAW #2 COVID 19&quot; services. The contract is a Blanket Purchase Agreement (BPA) call with a firm fixed price of $144,665.85. The period of performance ends on September 30, 2020. Emory University, a private research university located in Atlanta, Georgia, has an extensive track record of performing federally funded research and...
This firm fixed-price purchase order was awarded to Emory University, a private research institution in Atlanta, Georgia, by the Centers for Disease Control and Prevention (CDC) Pittsburgh office. The $90,000.00 contract is for an IRB-approved study under the Emory University Center for AIDS Research. The contract has no set-aside designation and is set to be completed by September 20, 2022. Emory University, through its Office of Sponsored Programs Division, has an extensive track record of...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm fixed-price purchase order to Emory University for $149,994.00 to provide clinical researcher support services. The contract did not have a set-aside designation. The award is for work to be performed in Atlanta, Georgia, with a completion date of February 28, 2019. Emory University is a private research university that provides a range of services to the federal government, including clinical...

Emory University is receiving $348,253.49 under a firm fixed price definitive contract from the Department of Health and Human Services Centers for Disease Control and Prevention. The contract was awarded on September 30th, 2020 to support COVID-19 BAA Topic 2 efforts, with work expected to be completed by March 28th, 2022. No set-aside designation was specified. Emory University will serve as the prime contractor, engaged to assist the CDC in assessing cloth face coverings as a means of source control under laboratory and simulated conditions. Georgia State University Research Foundation and Georgia Tech Research Corporation are major subcontractors on the award to provide additional support evaluating face coverings. As the nation's leading public health agency, the CDC is actively involved in COVID-19 response efforts such as furthering understanding of disease transmission dynamics and developing guidance on risk mitigation strategies.

Generated 1/23/24, 3:59 PM